Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 4.85 CHF 0.73% Market Closed
Market Cap: 178.8m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Other Current Assets
CHf3.1m
CAGR 3-Years
-42%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Other Current Assets
$16.3m
CAGR 3-Years
18%
CAGR 5-Years
59%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Other Current Assets
CHf3.4m
CAGR 3-Years
-18%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Other Current Assets
$8.2m
CAGR 3-Years
-42%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Other Current Assets
CHf11.7m
CAGR 3-Years
32%
CAGR 5-Years
19%
CAGR 10-Years
12%
Kuros Biosciences AG
SIX:KURN
Other Current Assets
CHf1.7m
CAGR 3-Years
32%
CAGR 5-Years
38%
CAGR 10-Years
N/A
No Stocks Found

Molecular Partners AG
Glance View

Market Cap
178.8m CHF
Industry
Biotechnology

Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 163 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

MOLN Intrinsic Value
3.07 CHF
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Molecular Partners AG's Other Current Assets?
Other Current Assets
3.1m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Other Current Assets amounts to 3.1m CHF.

What is Molecular Partners AG's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-5%

Over the last year, the Other Current Assets growth was -25%. The average annual Other Current Assets growth rates for Molecular Partners AG have been -42% over the past three years , -5% over the past five years .

Back to Top